Shopping News / Articles
Mifepristone tablets sit on a table at a Planned Parenthood clinic in Ames, Iowa.
7+ hour, 4+ min ago (19+ words) Findlay News | The Courier...
Abortion pill mifepristone stays available by mail for now as FDA faces 6-month review deadline
1+ day, 14+ hour ago (926+ words) A federal judge allowed the abortion pill mifepristone to continue being distributed by mail nationwide for now, but warned the Biden-era policy could soon face major legal changes as a Food and Drug Administration (FDA) safety review of the drug…...
Vasudev Bhupathi: A Distinguished Figure in Pharmacovigilance
5+ day, 20+ hour ago (327+ words) An expert pharmacovigilance and clinical safety leader with more than 20 years of experience in his field, Vasudev Bhupathi works to ensure the safety and efficacy of pharmaceutical products. Bhupathi manages global drug safety strategies related to oncology, immuno-oncology, infectious diseases,…...
Alto suffers mid-stage blow for schizophrenia drug, ramps up lead depression programme
1+ week, 8+ hour ago (14+ words) First Word Pharma...
PK Activation Gains Momentum in Thalassemia Agios" Aqvesme Launch Reflects Strong Promise with Deliberate Uptake
1+ week, 2+ day ago (300+ words) These early findings highlight a familiar but important pattern: strong clinical enthusiasm paired with cautious early adoption," said Sarah Hendry, Franchise Head of Hematology at Spherix Global Insights. Physicians clearly see the value of PK activation, but patient selection and…...
SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too
1+ week, 2+ day ago (638+ words) NEW ORLEANS, LA'Mavacamten (Camzyos; Bristol Myers Squibb) better reduces left ventricular outflow tract (LVOT) obstruction than placebo among adolescent patients with obstructive hypertrophic cardiomyopathy (HCM), according to data from the SCOUT-HCM phase III trial. In 2022, the US Food and Drug…...
Bristol Myers Squibb Presents Positive Results From Phase 3 Scout-Hcm Trial Demonstrating Efficacy And Safety Of Camzyos (Mavacamten) In Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy (Ohcm)
1+ week, 4+ day ago (59+ words) Trading View Bristol Myers Squibb Presents Positive Results From Phase 3 Scout-Hcm Trial Demonstrating Efficacy And Safety Of Camzyos (Mavacamten) In Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy (Ohcm) More news from Reuters...
Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026
2+ week, 17+ hour ago (273+ words) Trial demonstrated no safety concerns when co-administering roluperidone and olanzapine The Company continues to advance the program, with the. .. Trial demonstrated no safety concerns when co-administering roluperidone and olanzapine The Company continues to advance the program, with the confirmatory Phase…...
Minerva Presents Safety Trial Data on Roluperidone, Olanzapine
1+ week, 6+ day ago (556+ words) The Clinical Trial Vanguard Minerva Presents Safety Trial Data on Roluperidone, Olanzapine Minerva Neurosciences reported that an open-label safety study of roluperidone coadministered with olanzapine showed no clinically significant adverse effects and no meaningful PK or PD interactions. The company…...
US FDA Approves Avlayah To Treat Neurologic Manifestations Of Hunter Syndrome
2+ week, 1+ day ago (26+ words) Trading View US FDA Approves Avlayah To Treat Neurologic Manifestations Of Hunter Syndrome More news from Reuters...
Shopping
Please enter a search for detailed shopping results.